Rogers Communication Shares Hit 4-Year High

Rogers Communication Shares Hit 4-Year High

Rogers Communication shares briefly touched their highest level since May 2013 on Thursday after the company said that Joe Natale will finally join the company on April 19. Rogers announced Natale’s appointment in October of last year and said Thursday that his joining the company now was possible after he reached a confidential agreement with Telus Corporation (TU). Natale was formerly CEO of Telus and was under a non-compete agreement […]

Read More ˃
Bond Prices Extend Gains

Bond Prices Extend Gains

U.S. Treasury prices continued to rise as ongoing geopolitical issues drew safe-haven buying with the latest reports of smoke rising from near the Moscow airport. Treasury supply is being eyed with caution, with the past six sales having seen mixed results, although the March auction went very well. The subpar three-year sale Monday and lack of concession in today’s trade has some leaning pessimistic, although foreign buyers are expected to […]

Read More ˃
Stage Stores Completes Acquisition of Selected Gordmans Assets

Stage Stores Completes Acquisition of Selected Gordmans Assets

Stage Stores said Friday that it has closed its previously announced acquisition of selected assets of Gordmans Stores, Inc., including a minimum of 50 Gordmans store leases, with rights to assume leases for an additional seven stores and a distribution center; all of Gordmans’ inventory, furniture, fixtures, equipment and other assets at the 57 store locations; and trademarks and other intellectual property of Gordmans. SSI shares were down 2% in […]

Read More ˃
AstraZeneca to Make $12 Mln Milestone Payment

AstraZeneca to Make $12 Mln Milestone Payment

AstraZeneca will make a $12 million milestone payment to Heptares Therapeutics, a wholly-owned unit of Sosei Group Corp., as Heptares achieved a significant milestone in its immuno-oncology collaboration with the UK-based drugmaker. Heptares said its collaboration with AstraZeneca is focused on the development of AZD4635 as a potential new treament for various cancers. AZD4635 was discovered by Heptares and licensed to AstraZeneca in 2015. The milestone was triggered by the […]

Read More ˃
Cowen Group Buys Convergex

Cowen Group Buys Convergex

Cowen Group said early Monday it has acquired Convergex Group for about $116 million in a cash and shares. The company signed a takeover agreement with private-equity firm GTCR, Bank of New York Mellon, and other shareholders, it said in a statement. With combined pro forma brokerage execution revenues of more than $400 million in 2016, Cowen said the transaction expands its reach to 108 countries globally, including China. The […]

Read More ˃